Sapient Capital LLC Takes $39,000 Position in iCoreConnect Inc. (NASDAQ:ICCT)

Sapient Capital LLC purchased a new position in shares of iCoreConnect Inc. (NASDAQ:ICCT) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 31,256 shares of the company’s stock, valued at approximately $39,000. Sapient Capital LLC owned about 0.35% of iCoreConnect at the end of the most recent quarter.

Separately, Cowen AND Company LLC acquired a new position in shares of iCoreConnect during the 3rd quarter valued at about $60,000. Institutional investors own 13.42% of the company’s stock.

iCoreConnect Stock Down 2.5 %

iCoreConnect stock opened at $1.18 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.40 and a current ratio of 0.40. The company has a 50-day moving average price of $1.24 and a 200 day moving average price of $1.38. iCoreConnect Inc. has a 12-month low of $0.12 and a 12-month high of $20.70.

iCoreConnect (NASDAQ:ICCT) last released its quarterly earnings results on Thursday, April 18th. The company reported ($0.94) EPS for the quarter. The firm had revenue of $2.45 million for the quarter.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.